日本語View as Markdown

Successful treatment with hydrogen rich water in a case of chronic graft-versus-host-disease.

水素豊富水摂取による慢性移植片対宿主病の1症例報告

human case report hydrogen-rich water positive

Abstract

Chronic graft-versus-host disease (cGVHD) is a serious complication following allogeneic hematopoietic stem cell transplantation, with inflammation and fibrosis identified as central pathogenic mechanisms. Molecular hydrogen possesses anti-inflammatory, antioxidant, and anti-fibrotic properties, suggesting potential relevance to cGVHD pathophysiology. This case report describes a patient with severe cGVHD who consumed hydrogen-rich water and experienced notable clinical improvement. The authors propose that oral intake of hydrogen-rich water may represent a safe and potentially beneficial approach for managing this difficult condition, warranting further investigation in controlled settings.

Mechanism

Molecular hydrogen's anti-inflammatory, antioxidant, and anti-fibrotic properties may suppress the inflammation and fibrosis that underlie cGVHD pathogenesis.

Bibliographic

Authors
Qian L, Shen J
Journal
Med Gas Res
Year
2016
PMID
27867488
DOI
10.4103/2045-9912.191366
PMC
PMC5110137

Tags

Disease:移植片対宿主病 Delivery:水素水経口投与 Mechanism:抗酸化酵素 免疫調節 炎症抑制 酸化ストレス

Delivery context

Hydrogen-rich water is a low-risk delivery route, but the achievable systemic hydrogen dose is bounded. For clinical applications, inhalation is the most efficient route; inhalation, however, carries explosion risk, and concentration matters (empirical LFL of 10% applies to inhalation environments; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).

Safety notes

Hydrogen-rich water is a low-risk delivery route, but the achievable systemic hydrogen dose is bounded. For clinical applications, inhalation is the most efficient route; inhalation, however, carries explosion risk, and concentration matters (empirical LFL of 10% applies to inhalation environments; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 27867488. https://h2-papers.org/en/papers/27867488
Source: PubMed PMID 27867488